Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement:: the RE-MODEL randomized trial
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement:: the RE-MODEL randomized trial
复制标题
DOI：
10.1111/j.1538-7836.2007.02748.x
复制
发表时间：
2007-11-01
影响因子：
10.4
通讯作者：
Buller, H. R.
中科院分区：
文献类型：
--
作者：
Eriksson, B. I.;Dahl, O. E.;Buller, H. R.
